Jaguar Health Inc JAGX

US Pharmaceuticals

$1.00 ▼ -3.85% ($-0.04)

🗓️ Earnings Next Week

Open $1.02

Prev Close $1.04

Day Range $1.00 – $1.07

52W Range $0.91 – $92.75

Market Cap $4.91M

Beta -0.07

EPS (TTM) $-713.94

📋 Company Profile

Industry	Pharmaceuticals
Country	US
Exchange	NASDAQ NMS - GLOBAL MARKET
Currency	USD
IPO Date	2015-05-13
Shares Out.	4,910,000
Website	jaguar.health/ ↗
Phone	13026587581
Employees	47
Revenue	$20.3M
Gross Profit	$19.1M
Net Income	$8.7M
Free Cash Flow	-$7.6M
Total Assets	$37.4M
Total Liabilities	$53.2M
Equity	-$15.8M

About Jaguar Health Inc

Jaguar Health Inc is a commercial-stage pharmaceutical company developing novel proprietary prescription medicines sustainably derived from plants from rainforest areas for gastrointestinal disease states in humans and animals. The Company focuses on conditions associated with overactive bowel, including chronic debilitating diarrhea, urgency, and bowel incontinence. It operates through two segments: animal health, which develops and commercializes products for animals, and human health, with the human health segment generating the maximum revenue and focusing on products such as Mytesi, focusing on human products, specifically Mytesi, approved for symptomatic relief of non-infectious diarrhea in adults with HIV/AIDS on antiretroviral therapy.

Jaguar Health Inc is a publicly traded company under the ticker symbol JAGX on the NASDAQ NMS - GLOBAL MARKET, operating in the Pharmaceuticals industry. Quotes and metrics shown here are sourced from public market data and refreshed regularly.